Model
Edge
Halozyme Therapeutics, Inc.
0001324015
Filing Type
4
Filing Date
3/31/2025
Updated
4/1/25, 4:32 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership